Form 4: Omada Health CFO Sells Shares Under 10b5-1 Plan

Omada Health's Chief Financial Officer, Steven L. Cook, has reported the sale of 17,950 shares of common stock under a pre-arranged 10b5-1 trading plan.

Summary

• Steven L. Cook, Chief Financial Officer of Omada Health, Inc. (OMDA), sold 17,950 shares of common stock.
• The transaction occurred on June 22, 2026, with a weighted average sale price of $18.1278 per share.
• The shares were sold as part of a Rule 10b5-1 trading plan adopted by Mr. Cook on March 14, 2026.
• Following the transaction, Mr. Cook beneficially owns 169,259 shares of Omada Health common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While an executive selling shares can be a negative signal, the transaction was conducted under a pre-established 10b5-1 plan, indicating a planned liquidity event rather than a reaction to adverse company information.

Negatives

• Sale of a significant number of shares by a key executive, which could be perceived negatively by the market.

Risks

• The sale was executed under a 10b5-1 plan, which is designed to mitigate insider trading concerns, but the timing and volume of sales can still influence market perception.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports a past transaction.

Management Comments

• The transaction was executed in multiple trades at prices ranging from $18.00 to $18.30. The price reported above reflects the weighted average price.
• The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Industry Context

StockSavvy.ai notes that insider sales, even under a 10b5-1 plan, can sometimes lead to increased scrutiny from investors regarding management's confidence in the company's future prospects. However, the existence of the plan itself is a standard practice to allow for planned liquidity events without raising insider trading concerns.

Stakeholder Impact

• Shareholders: May interpret the sale as a sign of reduced confidence by management, potentially impacting short-term stock price. However, the 10b5-1 plan mitigates this concern to some extent.
• Employees: Similar to shareholders, employees may view insider sales with caution, though the planned nature of the sale is a mitigating factor.
• Management: The sale allows the CFO to diversify personal assets or meet financial obligations, a standard practice for executives.

Key Dates

Keywords

Omada Health, OMDA, Form 4, Insider Trading, 10b5-1 Plan, Stock Sale, Steven L. Cook, Chief Financial Officer, Beneficial Ownership